Source:http://linkedlifedata.com/resource/pubmed/id/21107126
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
2010-11-25
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
1536-5166
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
30
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
376-8; discussion 378-9
|
| pubmed:meshHeading | |
| pubmed:year |
2010
|
| pubmed:articleTitle |
Should most patients with optic neuritis be tested for neuromyelitis optica antibodies and should this affect their treatment?
|
| pubmed:affiliation |
Department of Neurology, Philadelphia, Pennsylvania 19104, USA. galetta@mail.med.upenn.edu
|
| pubmed:publicationType |
Journal Article
|